Diabetes Stocks List

Diabetes Stocks Recent News

Date Stock Title
Jul 11 TNDM Tandem Diabetes Care to Announce Second Quarter 2024 Financial Results on August 1, 2024
Jul 11 LXRX Private equity firms account for 48% of Lexicon Pharmaceuticals, Inc.'s (NASDAQ:LXRX) ownership, while individual investors account for 33%
Jul 10 TNDM Glaukos cut as Citi reviews U.S. MedTechs ahead of Q2 results
Jul 10 MRK Prelude and MSD partner to trial PRT3789 and Keytruda combination
Jul 9 EHAB Enhabit Home Health & Hospice Announces Date of 2024 Second Quarter Earnings Call
Jul 9 HUMA Pluristyx Announces License Agreement with Humacyte to Develop BioVascular Pancreas using iPSCs
Jul 9 MRK Is Merck & Co., Inc. (MRK) Among the Best Blue Chip Dividend Stock to Buy Right Now?
Jul 9 MRK Merck Animal Health Completes Acquisition of Elanco’s Aqua Business
Jul 9 MRK Elanco Completes Sale of Aqua Business
Jul 9 MRK Prelude, Merck strike clinical trial collaboration and supply pact
Jul 9 LXRX Strength Seen in IDEAYA Biosciences (IDYA): Can Its 15.3% Jump Turn into More Strength?
Jul 8 LXRX Lexicon appoints Mike Exton as CEO, Jeff Wade as COO
Jul 8 LXRX Lexicon Board of Directors Appoints Mike Exton, Ph.D. as New Chief Executive Officer and Director
Jul 8 EHAB Enhabit Reiterates That its Current Board is Best Positioned to Deliver Enhanced Value in Letter to Stockholders
Jul 7 MRK EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
Jul 5 EHAB AREX Capital Expresses Disappointment in Enhabit’s Continued Excuses and Empty Promises
Jul 5 MRK Roche's New Immunotherapy Fails To Show Benefit Over Merck's Blockbuster Keytruda In Lung Cancer Patients
Diabetes

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags